betaxanthin

structure in first source

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Allegra, Mario: 1 article (01/2021)
2.	Almerico, Anna Maria: 1 article (01/2021)
3.	Attanzio, Alessandro: 1 article (01/2021)
4.	Culletta, Giulia: 1 article (01/2021)
5.	Tesoriere, Luisa: 1 article (01/2021)
6.	Tutone, Marco: 1 article (01/2021)
7.	Gandía-Herrero, Fernando: 1 article (07/2020)
8.	García-Carmona, Francisco: 1 article (07/2020)
9.	Guerrero-Rubio, M Alejandra: 1 article (07/2020)
10.	Henarejos-Escudero, Paula: 1 article (07/2020)

1.	Shock 12/01/2017 - "A strong thermal shock, provided by convection at 60° followed by microwave wattage 315W/9min, leads to a better preservation of bioactive compounds content (0.631±0.0042mg/g of betacyanin and 0.795±0.0019mg/g betaxanthin) when compared to convection at 50, 60 and 70°C. "
2.	Neoplasms (Cancer) 07/22/2020 - "Our results indicate that tryptophan-betaxanthin and related betalains are strong candidates as antitumoral molecules in cancer treatment." 07/22/2020 - "Among the betalains tested, tryptophan-betaxanthin reduced tumor size by 56.4% and prolonged the animal's lifespan by 9.3%, indicating high effectiveness and low toxicity. "
3.	Melanoma (Melanoma, Malignant) 01/01/2021 - "Background: Indicaxanthin, a betaxanthin belonging to the betalain class of compounds, has been recently demonstrated to exert significant antiproliferative effects inducing apoptosis of human melanoma cells through the inhibition of NF-κB as the predominant pathway. "
4.	Adenocarcinoma 03/09/2023 - "Tytus flesh also showed a high cytotoxicity value against human cervical adenocarcinoma (HeLa), with CC50 of 282 μg/mL. Correlation analysis was used to determine the relationship between the betaxanthin profiles and antimicrobial and anticancer activities. "